These anti-PNMA1-autoantibodies cross-react with the nervous system structures inducing vast neurological impairments like limbic and extra- limbic encephalopathies, Bergmann gliosis, cerebellar ataxia, etc.81. This evidence concerns the gene PNMA1 and aceruloplasminemia.